Dr. Chang Z. Zhu, Senior Research Scientist of Abbott Neuroscience and pain research, received his M.D and M.S. in Neuroscience from Tingdao and Shandong University, P.R. China in 1980 and 1984, respectively. Chang then served as an neurologist in Shandong Provencial Hospital, and Stroke Research Fellow at University of Toronto. Chang joined Abbott Laboratories in 1995. Chang has played a leading role of in vivo effort in various pain programs at Abbott including Adenosine Kinase Inhibitor, purinergic P2X3 receptor inhibitor, NNRs agonists and calcium channels blockers. Chang has invented Carrageenan-induced locomotor activity impairment model for objective assessment of inflammatory pain, has authored or co-authored more than 60 scientific papers, focusing on cerebral ischemia and pain research.
Biography Updated on 21 May 2012